VI Partners AG is a private equity general partner firm headquartered in Zug, Switzerland.
Inositec, a Switzerland-based developer of life-saving small molecule drugs based on inositol hexaphosphate, closed CHF1.4m in seed funding.
Gamaya, which provides services of airborne crops monitoring in agriculture, has raised CHF3.2m in Series A financing round.
Amal Therapeutics, a Switzerland-based biotech company, completed a CHF3m in Series A funding led by Boehringer Ingelheim Venture Fund.
Read more news concerning VI Partners AG
A sampling of VI Partners AG portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?